Green Alpha Advisors, LLC

Position in PRME — Prime Medicine, Inc.

CIK 1439207 NIWOT, CO

Position in PRME

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$682,734

+$17,459 QoQ

Shares Held

185,023

-3.2% QoQ

Ownership

0.102%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#51

of 186 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Green Alpha Advisors, LLC holds $9,323,372 across 14 Biotechnology names. PRME ranks #3 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	55,804	$3,043,550
2	MRNA	Moderna, Inc.	33,758	$2,364,072
3	PRME	Prime Medicine, Inc. This page	185,023	$682,734
4	CRBU	Caribou Biosciences, Inc.	364,324	$641,210
5	RXRX	Recursion Pharmaceuticals, Inc.	147,544	$541,486
6	EDIT	Editas Medicine, Inc.	156,046	$505,589
7	VRTX	Vertex Pharmaceuticals Inc / Ma	552	$274,194
8	BEAM	Beam Therapeutics Inc.	7,569	$259,768

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$682,734	185,023	-3.2%	Shares	Sole	2026-08-11
2026-03-31	$665,275	191,171	+0.2%	Shares	Sole	2026-04-07
2025-12-31	$662,364	190,883	+0.3%	Shares	Sole	2026-01-07
2025-09-30	$1,054,555	190,353	+141.0%	Shares	Sole	2025-10-15
2025-06-30	$195,115	78,994	-5.4%	Shares	Sole	2025-08-01
2025-03-31	$166,099	83,467	+29.6%	Shares	Sole	2025-04-09
2024-12-31	$188,065	64,406	+145.4%	Shares	Sole	2025-01-13
2024-06-30	$134,899	26,245	-22.2%	Shares	Sole	2024-08-13
2024-03-31	$236,166	33,738	+14.2%	Shares	Sole	2024-04-10
2023-12-31	$261,706	29,538	-21.9%	Shares	Sole	2024-01-05
2023-09-30	$360,755	37,815	+205.3%	Shares	Sole	2023-10-10
2023-06-30	$181,454	12,386	—	Shares	Sole	2023-07-06
No filing history on record for this holder in this stock.